EGG-FLEX: precision hydrolysis and fractionation of egg protein ingredients

Overview

EGG-FLEX is a scalable, food-grade platform that converts egg protein ingredients into differentiated functional protein and peptide ingredients. By coupling controlled enzymatic hydrolysis with membrane fractionation and drying, the platform produces hydrolysates and peptide fractions with tailored solubility, viscosity, heat stability, emulsification, and sensory properties. It is designed to generate multiple value-added ingredients from a single egg-derived feedstock, creating new opportunities for high-protein beverages and nutrition products.

The approach addresses a key industry challenge: excessive protein hydrolysis can improve functionality but often creates bitterness and weakens processing performance. EGG-FLEX solves this by precisely controlling hydrolysis and then fractionating the resulting peptides by molecular weight, so each ingredient stream can be matched to a specific application rather than sold as an undifferentiated hydrolysate.

Technical specifications

Core technology elements:

• Food-grade enzymatic hydrolysis using selected proteases, with processing conditions optimized for degree of hydrolysis and peptide profile.
• Membrane separation that fractionates hydrolysates by molecular weight to create ingredient streams with defined functional and sensory characteristics.
• Food-compatible debittering used when needed to reduce bitterness while preserving functionality.
• Drying and final formulation into ingredient powders for food and beverage prototypes.

Key parameters evaluated:

• Enzyme concentration, time, temperature, and degree of hydrolysis.
• Protein recovery, peptide profile, solubility, viscosity, heat stability, emulsification capacity, and sensory properties.
• Processing–composition–function relationships that guide selection of lead ingredients for specific applications.

Intended benefits:

• Multiple customized protein ingredients from one egg-derived feedstock.
• Reduced bitterness compared with conventional hydrolysates.
• Scalable, food-grade unit operations including enzymatic processing, membrane filtration, and drying.

Technology readiness level

The platform is at an early development stage, with a defined pathway toward commercial application. The proposed research includes phase-based validation: hydrolysis optimization, membrane fractionation and peptide characterization, ingredient development with debittering, and validation in high-protein beverage and nutrition prototypes. Future work will assess mass balance, scalability, and preliminary manufacturing economics to establish a commercial pathway. At this stage, the technology represents laboratory-to-pilot-scale proof of concept, with further validation required before full commercial deployment.